Conference Reports for NATAP

IDWeek October 3 -7, 2018 San Francisco, CA Back

A RETROSPECTIVE STUDY TO EVALUATE THE SAFETY AND EFFICACY OF A NUCLEOSIDE-SPARING REGIMEN OF DARUNAVIR, RITONAVIR AND DOLUTEGRAVIR       Reported by Jules Levin IDWeek Oct 3-7 SF 2018   John Verna, PA-C, AAHIVS, Stephen Austin, MS